Market is Huge -- in two ways..both in the number of drugs available as generics, and the Canadian market dollar size for Generics ..To get 52 drugs (including those pending) to market in under a year is a fantastic feat of business plan execution by NPH managment....The only other significant Canadian company (which is more Eastern based than Western) in the generics sector, took 40 years to get 250 drugs, where they are now.... BTW the other few competitors are non-Canadian centered (and also remove provits from the Canadian tax system) to off shore low tax jurisdictions.. which I consider "unfriendly" to Canada... and I think Gov may not be a fan of this setup either..
In terms of market size it is massive and growing , Canada is about $30 Billion and will grow fast with the aging population...and as commodities correct down, Governments will be pushing generics to lower health care costs (insured by govt), and should also push to ensure comoanies are paying their fair share of Canadian tax to offset reduced revenues from natural resources... NPH ticks all of the boxes here..
As a longer term nugget, notice that our CEO has expertise in offshore markets doing complete start ups of generic companies -- for example in Brazil...